Tongkat Ali and Testosterone: An Evidence-Boundary Review

Does Tongkat Ali increase testosterone? Some human studies of defined Eurycoma longifolia supplements, mostly extracts, have reported testosterone-related outcomes. Study populations, materials, doses, and durations vary, so the findings do not automatically establish an effect for dried root tea or this specific product batch.

Tongkat Ali (Eurycoma longifolia) is often marketed as though “supports testosterone” were a settled property of every capsule, powder, and piece of root sold under the same plant name. The research does not justify that shortcut.

The most accurate summary is narrower: a limited body of human research, much of it using manufactured or standardized extracts, has examined testosterone-related outcomes. A 2022 systematic review and meta-analysis reported a possible increase in total testosterone, while also highlighting important limitations in the available studies. That evidence can inform a discussion about the studied extracts. It does not automatically establish the composition, dose, absorption, or clinical effect of dried root tea, and it does not validate our current product batch.

This distinction is the central evidence boundary for this article:

Standardized extract ≠ dried root tea ≠ this product batch.

The three may share a botanical source, but they are not the same intervention.

What testosterone is—and what symptoms cannot prove

Testosterone is an androgen involved in sexual development, reproductive function, bone, muscle, red-blood-cell production, and aspects of mood and energy. Levels vary by time of day, age, health status, medication use, sleep, calorie intake, and laboratory method.

Fatigue, reduced libido, low mood, poor recovery, and changes in body composition can occur alongside low testosterone. They can also have many other causes, including sleep apnea, thyroid disease, anemia, depression, medication effects, overtraining, undernutrition, diabetes, and cardiovascular illness. Feeling tired does not diagnose a hormone deficiency, and feeling more alert after drinking an herbal tea does not demonstrate that testosterone increased.

Clinical assessment usually relies on symptoms, medical history, and appropriately timed laboratory measurements, often repeated when a result is low. A supplement should not be used as a substitute for that evaluation.

What the 2022 meta-analysis found

The most useful high-level source for this question is Leisegang and colleagues’ 2022 systematic review and meta-analysis:

• PubMed 36013514
• DOI 10.3390/medicina58081047

The authors pooled controlled clinical evidence concerning Eurycoma longifolia supplementation and testosterone in men. Their analysis suggested that supplementation may increase total testosterone, with a signal that could be more relevant in men who already had lower levels.

Selected human-study details

The following cards describe the materials reported by their original PubMed records. They are not dosing guidance and they do not establish an equivalent amount of dried root tea.

Study-material notice: These findings concern the study material described in the original research and should not automatically be treated as evidence for dried root slices or this specific product batch.

That wording matters. A meta-analysis can summarize the studies available to it, but it cannot repair their underlying differences. The included literature was limited by factors such as:

• a small number of eligible trials;
• modest participant numbers;
• different populations and baseline hormone status;
• different extract preparations and doses;
• different study designs and durations;
• uncertainty about comparability between commercial preparations;
• limited ability to assess long-term effectiveness and safety.

The review is therefore evidence of a research signal, not a universal guarantee. It does not show that all Tongkat Ali materials are chemically equivalent. It also does not answer whether a brewed quantity of dried slices delivers the same constituents in the same amounts as a studied extract.

Why frequently discussed trials need careful wording

Several earlier trials are frequently discussed in supplement marketing, including studies associated with Talbott- or Tambi-type extract protocols. These are commonly repeated with striking percentage claims. We do not rely on those promotional percentages here.

The responsible takeaway is simply that some human studies reported changes in hormone-related or wellbeing outcomes after participants took particular Tongkat Ali extracts under particular protocols. Those findings have been debated because study size, design, participant selection, product specificity, and reporting quality affect how confidently they can be generalized.

Even if an extract trial is accepted at face value, it tests the intervention described in that paper. It does not test:

• loose dried root slices prepared at home;
• every product labelled Eurycoma longifolia;
• “red,” “yellow,” or “black” trade categories as potency grades;
• our sourcing story or our current inventory;
• a guaranteed outcome for an individual customer.

This is why we omit the often-repeated headline percentages. Without the full context, such numbers create false precision and encourage an invalid product-to-trial comparison.

Extract, root tea, and batch are different evidence levels

1. Standardized or defined extracts

An extract is produced by processing plant material to concentrate or select soluble constituents. A standardized extract may be manufactured to meet a target level of a marker compound such as eurycomanone. That does not make every extract identical, but it can make dosing more reproducible within a study.

Most human research discussed in relation to testosterone used an extract. The exact preparation is part of the intervention—not a minor detail.

2. Dried root tea

Dried root slices are plant material rather than a standardized clinical extract. Brewing variables include slice mass and thickness, water volume, temperature, simmering time, repeated brewing, and the chemistry of the starting root. These variables affect what enters the drink.

Traditional use can explain cultural context and preparation practice. It cannot establish chemical equivalence to an extract or predict a laboratory hormone response.

3. This product batch

Our product is sold as dried root slices for brewing. We do not currently publish a batch-specific certificate of analysis stating its eurycomanone percentage. We also do not have a clinical study of this batch.

Accordingly, we cannot calculate an evidence-based conversion from a studied extract dose to a number of our slices. We cannot say that a cup contains a specified quantity of eurycomanone. We cannot promise that it changes testosterone.

For our current testing scope and its limits, see What We Test. For a source-by-source map of claims and evidence, see the Evidence Index.

Eurycomanone does not bridge the gap by itself

Eurycomanone is a quassinoid used as a chemical marker in Tongkat Ali research and standardization. Laboratory and animal work has explored possible effects on steroidogenic pathways. These studies can help generate hypotheses, but they do not establish a clinical testosterone effect in humans drinking an unstandardized tea.

Three common reasoning errors should be avoided:

1. A compound is present in the species, therefore it is present at a known dose in this batch.
   Presence and concentration are different claims. Without a batch assay, the percentage is unknown.

2. A compound affects cells or animals, therefore a brewed root tea changes human hormones.
   Laboratory exposure, metabolism, dose, and human clinical outcomes are not interchangeable.

3. The tea tastes bitter, therefore it contains a clinically effective eurycomanone dose.
   Bitterness can come from multiple compounds. Taste is not a quantitative assay and cannot replace chromatography or a validated laboratory method.

For a fuller treatment, read Eurycomanone: Marker Compound, Not a Batch Guarantee.

What plausible mechanisms do—and do not—tell us

Researchers have discussed several possible pathways, including effects on steroidogenesis, stress physiology, and hormone availability. Mechanistic evidence is useful for deciding what to study next. It is weaker than direct, replicated clinical evidence for a defined intervention.

A plausible mechanism does not answer:

• whether enough of the relevant constituent survives brewing;
• whether it is absorbed at a meaningful level;
• whether effects seen in a selected research group apply to healthy buyers;
• whether a short-term biomarker change improves symptoms or health;
• whether benefits persist;
• whether long-term use is safe for a particular person.

Claims about lowering sex hormone-binding globulin, directly stimulating Leydig cells, “freeing” testosterone, or balancing the cortisol-to-testosterone ratio should therefore not be presented as established effects of our tea. Some originate in preclinical work or product-specific studies. They remain hypotheses when applied to an unassayed root batch.

What the evidence does not show

Current research does not justify saying that Tongkat Ali root tea:

• treats hypogonadism;
• replaces testosterone therapy;
• reliably raises total or free testosterone;
• restores libido, muscle, mood, or performance by increasing hormones;
• works within a promised number of weeks;
• is clinically equivalent or superior to a standardized extract;
• can be dosed by bitterness, color, region, “wild” status, or slice count for a hormonal outcome;
• is effective merely because an extract carrying the same species name was studied.

The distinction between “not proven” and “proven not to work” is important. Lack of direct evidence does not demonstrate no effect. It means the effect and its size are uncertain, so marketing should not turn that uncertainty into a promise.

Safety and medical context

“Natural” does not mean risk-free. Published safety information varies by preparation, and short extract studies cannot establish long-term safety for every root product. Product identity, adulteration, contaminants, dose, and individual health all matter.

Seek medical advice before use if you:

• have symptoms of low testosterone or infertility;
• have a hormone-sensitive condition;
• use testosterone, fertility treatment, corticosteroids, or other prescription medicines;
• have significant liver, kidney, cardiovascular, or psychiatric illness;
• are pregnant, trying to become pregnant, or breastfeeding;
• are considering the product for a child or adolescent.

Stop using it and seek advice if you develop a concerning reaction. Do not delay investigation of persistent fatigue, sexual dysfunction, mood change, or sleep problems.

The broader 2012 Natural Standard review is useful as historical background, not proof of efficacy for our product: DOI 10.3109/19390211.2012.761467.

How to read a Tongkat Ali testosterone claim

Before accepting a claim, ask:

1. Was the evidence from humans, animals, or cells?
2. What exact preparation was tested?
3. Was it standardized, and to what independently verified specification?
4. Were participants deficient, symptomatic, stressed, infertile, or healthy?
5. Was there a placebo or comparator?
6. Was the trial large enough and long enough to answer the question?
7. Is the seller offering the tested product—or only the same botanical name?
8. Is there a batch-specific report, and does it actually test the claimed constituent?
9. Is the claim about a laboratory marker being expanded into a promise about energy, masculinity, or performance?

If the product cannot be connected to the intervention through composition and dose, the study should be treated as botanical background rather than product proof.

A careful conclusion

The 2022 meta-analysis supports continued research into defined Tongkat Ali supplementation and testosterone. It does not support declaring every Tongkat Ali product a proven testosterone booster.

For our dried root slices, the evidence boundary is straightforward: they are not the standardized extracts dominant in the human literature; no published batch-specific eurycomanone percentage is available; and no clinical trial has tested this batch. People may still value the plant’s traditional brewing practice, but that preference should be separated from a medical or hormonal claim.

If you want to review the product as a traditional dried root rather than as a promised hormone intervention, you may view the product information. This is not a recommendation to treat low testosterone.

Related reading

• Tongkat Ali and Cortisol: What Is Actually Known
• Eurycomanone: Marker Compound, Not a Batch Guarantee
• What We Test
• Evidence Index